Protix
Dutch producer that farms insects into protein for animal feed and pet food.
Protix holds real regulatory and genetics assets in a European insect-protein model that has stopped paying for itself, now betting its future on unsigned Asia joint ventures.
Protix breeds black soldier fly larvae and processes them into protein and fat for livestock and pet food. It owns factory permits and genetics that are hard to copy, but European production has become unprofitable as prices fell and competitors like Ÿnsect went bankrupt, forcing the company to abandon expansion plans in Poland and Nebraska. The company is now betting everything on a joint venture in South Korea with a local partner called Reco, but if that deal stalls like the earlier ones did, it will signal the entire business model may be broken; meanwhile, much larger competitors like Darling Ingredients and Tyson Foods already have their own insect-protein operations backed by billions in capital, making it unclear whether Protix can survive on its own.
Tyson Foods formally exits or restructures the paused Nebraska joint facility. Would show a strategic partner is stepping back rather than in-sourcing insect protein with Protix.
Protix publishes an audited revenue figure. Would resolve whether actual revenue is near $12M or near $380M, clarifying financial health.
- Tyson and Protix halted the Nebraska facility investment
- Poland plant project put on hold
- Peer Ynsect ordered into liquidation by French court
- Financial health unknowable due to wildly conflicting, unaudited revenue figures across data providers.
- Repeated capex retreats: Poland plant shelved Feb 2025, Nebraska/Tyson facility paused Apr 2026.
- New growth strategy rests on unsigned, unfunded Southeast Asia JV (Reco MOU only, as of Mar 2026).
- EU feedstock regulation cited by CEO as blocking home-market cost competitiveness.
- Sector-wide distress (Ynsect liquidation, InnovaFeed suspension) signals broader insect-protein unit economics failure.
| Rival | Direction | Evidence |
|---|---|---|
| Darling Ingredients | gaining on | Owns EnviroFlight, a $3B+ balance sheet already inside insect-protein category, unlike Protix's shelved capex |
| Tyson Foods | contesting | Minority investor since 2023 (EUR 55M) yet paused joint Nebraska facility as of Apr 1, 2026 |
| Ynsect | gaining on | Ynsect ordered into liquidation (reported Apr 1, 2026) after raising ~$600M, reducing sector rival |
| InnovaFeed | gaining on | Suspended US pilot plant operations in August 2025 amid sector-wide unit economics stress |
- Is Protix profitable in 2026?
- No confirmed profit or audited revenue figure exists for Protix as of mid 2026. The company has shelved its Poland plant (Feb 2025) and paused the Tyson-backed Nebraska facility (Apr 1, 2026), suggesting cash-constrained retrenchment rather than profitable scaling.
- Who owns Protix?
- Protix is a private Dutch company, not publicly traded as of March 23, 2026. Tyson Foods became a minority strategic investor after putting in EUR 55M ($58.2M) in 2023, alongside earlier investors Aqua-Spark, Rabobank, and Invest-NL.
- Could AI replace Protix's business?
- No. Protix runs physical biomanufacturing (insect breeding, larval rearing, oil/protein extraction) that AI cannot substitute; its real exposure is commodity price competition against soy and fishmeal, not software disruption, per its 2026 evidence brief.
- Who is Protix's biggest competitor?
- Darling Ingredients, a $3B+ rendering and ingredients giant, already owns a direct black soldier fly rival, EnviroFlight, with far greater capital than Protix. Tyson Foods is simultaneously a minority investor (2023, EUR 55M) and a potential in-sourcing competitor.
- Did Protix's competitor Ynsect go bankrupt?
- Yes. Ynsect, which had raised roughly $600M for insect farming, was ordered into liquidation by a French commercial court, reported as of Apr 1, 2026, alongside InnovaFeed suspending its US pilot plant operations in August 2025.
- What is Protix's new strategy under its 2025 CEO?
- Since Nov 5, 2025, CEO Maiko van der Meer has pivoted Protix away from Europe and North America toward Southeast Asia joint ventures, citing EU feedstock cost rules; a South Korea MOU with Reco was signed by Mar 17, 2026, but not yet a funded facility.
- 2026-04-01Protix and Tyson Foods confirmed pause of Nebraska US insect facility investment
- 2026-03-17CEO announces pivot to Southeast Asia, cites EU cost disadvantage, Reco MOU signed
- 2025-11-05Maiko van der Meer replaces founder Kees Aarts as CEO
- 2025-03Invest International issues EUR 1M loan to support South Korea expansion
- 2025-02Poland production plant project confirmed on hold
- 2024-01-24EIB signs up to EUR 37M loan agreement for Polish plant, later cancelled
- 2023Tyson Foods invests EUR 55M (~$58.2M), becomes minority owner
- 2022-02Protix closes EUR 50M equity round led by ECBF and BNP Paribas
- 2017Protix raises EUR 45M in equity and debt from Aqua-Spark and Rabobank
- 2009Protix founded by Kees Aarts and Tarique Arsiwalla, former McKinsey colleagues
- Protix and Tyson Foods halt investment in US insect facility (2026-04-01)
- Protix (2026-03-23)
- EIB supports Protix in scaling up its sustainable protein production (2024-01-24)
- Protix names Maiko van der Meer as its new CEO (2025-11-05)
- Dutch insect ag firm Protix shifts focus to Asia (2026-03-17)
- Insect protein company Protix closes EUR 50 million fundraising round (2022)
- Protix Receives 45M€ in Funding to Scale Production of Insect Proteins (2018-06-26)
- Protix Company Overview
- Protix Stock Price, Funding, Valuation, Revenue & Financial Statements (2025-03-19)
- Protix - Overview, News & Similar companies
- Revenue, Competitors, Alternatives
- Insect Protein Market Size, Share, and Industry Trends Forecast 2026-2036 (2026-05-10)